| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jan.8 - The China Securities Regulatory Commission (CSRC) have started investigation1 into the fund misappropriation issues of 17 listed companies.
The 17 companies have failed to recover the 9.2 billion yuan (about 1.15 billion U.S. dollars) of debt by their controlling shareholders2 before the deadline, the end of 2006, a spokesman of the CSRC said here on Sunday. The companies include Sanjiu Medical & Pharmaceutical3 Co., China Textile Machinery4 Co. and Hebei Baoshuo Co.. Those who misappropriated funds in these companies will be prosecuted5 under the law, according to the spokesman. Thirty six companies failed to meet the deadline, involving a total of 14.6 billion yuan of misappropriated funds. However, the other 19 companies have come out with a plan to recover the money, escaping the investigation. The CSRC issued an ultimatum6 to listed companies in October 2005, requiring them to recover misappropriated funds by the end of 2006. Last year, 402 companies listed on the Shanghai and Shenzhen bourses recovered 33.57 billion yuan misappropriated by their controlling shareholders. The recover campaign was aimed to improve the quality of the country's 1,400 listed companies and safeguard the interests of shareholders. The misappropriation of large sums by controlling shareholders has been a major problem afflicting7 China's burgeoning8 stock markets.
点击收听单词发音
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TAG标签:
- 发表评论
-
- 最新评论 进入详细评论页>>